SAGE

Sage Therapeutics

Delisted

SAGE was delisted on the 30th of July, 2025.

190 hedge funds and large institutions have $3.06B invested in Sage Therapeutics in 2017 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 61 increasing their positions, 73 reducing their positions, and 23 closing their positions.

Holders
190
Holders Change
+1
Holders Change %
+0.53%
% of All Funds
4.74%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.1%
New
26
Increased
61
Reduced
73
Closed
23
Calls
$163M
Puts
$138M
Net Calls
+$24.8M
Net Calls Change
+$116M
Name Market Value Shares Shares
Change
Shares
Change %
Janney Montgomery Scott
201
Janney Montgomery Scott
Pennsylvania
-3,599 Closed
SM
202
Sabby Management
Florida
-3,379 Closed
Neuberger Berman Group
203
Neuberger Berman Group
New York
-3,000 Closed
Jane Street
204
Jane Street
New York
-2,921 Closed
BCM
205
BlueCrest Capital Management
Jersey
-2,881 Closed
PIM
206
Partner Investment Management
California
-1,572 Closed
NIT
207
NumerixS Investment Technologies
British Columbia, Canada
-700 Closed
PHK
208
Point72 Hong Kong
Hong Kong
-613 Closed
WP
209
WealthPLAN Partners
Nebraska
-230 Closed
SCM
210
Segantii Capital Management
Hong Kong
-200 Closed
FMA
211
FNY Managed Accounts
New York
-105 Closed
WVP
212
Worth Venture Partners
New Jersey
SCM
213
Sio Capital Management
New York
PA
214
Perceptive Advisors
New York
Hudson Bay Capital Management
215
Hudson Bay Capital Management
Connecticut
Carson Wealth (CWM LLC)
216
Carson Wealth (CWM LLC)
Nebraska
$0 6
FPF
217
FNY Partners Fund
New York
DAM
218
DLD Asset Management
New York
IA
219
IFP Advisors
Florida
$0 5
HT
220
HAP Trading
New York
Nomura Asset Management
221
Nomura Asset Management
Japan
ACP
222
Acuta Capital Partners
California